On November 13, 2017 CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will provide a corporate overview at the 29th Annual Piper Jaffray Healthcare Conference, the Evercore/ISI 2017 Biopharma Catalyst/Deep Dive Conference, and the Global Mizuho Investor Conference (Press release, CymaBay Therapeutics, NOV 13, 2017, View Source [SID1234521961]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

29th Annual Piper Jaffray Healthcare Conference
Date: Wednesday, November 29
Time: 12:00pm Eastern time
Location: Lotte New York Palace Hotel
Webcast: View Source;

Evercore/ISI 2017 Biopharma Catalyst/Deep Dive Conference
Date: Thursday, November 30
Time: 12:05pm Eastern Time
Location: Boston Harbor Hotel
Webcast: View Source;

Global Mizuho Investor Conference
Date: Tuesday, December 5
Time: One-on-One Format
Location: Lotte New York Palace Hotel